article
PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
Registro en:
ISSN: 1098-3015
EISSN: 1524-4733
Autor
Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
Institución
Resumen
To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.